Drug Profile
Esflurbiprofen transdermal - Teikoku Seiyaku
Alternative Names: TK-254R; TK-254RXLatest Information Update: 20 Sep 2023
Price :
$50
*
At a glance
- Originator Teikoku Seiyaku
- Class Analgesics; Antirheumatics; Biphenyl compounds; Fluorobenzenes; Nonsteroidal anti-inflammatories; Propionic acids
- Mechanism of Action Cyclo-oxygenase 1 inhibitors; Cyclo-oxygenase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Acute pain
Most Recent Events
- 18 Sep 2023 Teikoku Seiyaku plans a phase I trial for (In volunteers) in Germany (Transdermal, Topical) (NCT06042192)
- 06 Nov 2021 Teikoku Seiyaku completes a phase II clinical trials in Acute pain in Germany (Transdermal) (EudraCT2020-005165-14)
- 07 Apr 2021 Chemical structure information added